Understanding controlled trials -: What are pragmatic trials?

被引:525
|
作者
Roland, M [1 ]
Torgerson, DJ
机构
[1] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England
[2] Univ York, Ctr Hlth Econ, Natl Primary Care Res & Dev Ctr, York YO1 5DD, N Yorkshire, England
来源
BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7127期
关键词
D O I
10.1136/bmj.316.7127.285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:285 / 285
页数:1
相关论文
共 50 条
  • [21] Masking in Pragmatic Trials: Who, What, and When to Blind
    Jennifer B. Christian
    Emily S. Brouwer
    Cynthia J. Girman
    Dimitri Bennett
    Kourtney J. Davis
    Nancy A. Dreyer
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 431 - 436
  • [22] Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials
    Jenny L Donovan
    Sangeetha Paramasivan
    Isabel de Salis
    Merran Toerien
    Trials, 15
  • [23] Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials
    Donovan, Jenny L.
    Paramasivan, Sangeetha
    de Salis, Isabel
    Toerien, Merran
    TRIALS, 2014, 15
  • [24] Randomised controlled trials: understanding confounding
    Sedgwick, Philip
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [25] Understanding and misunderstanding randomized controlled trials
    Deaton, Angus
    Cartwright, Nancy
    SOCIAL SCIENCE & MEDICINE, 2018, 210 : 2 - 21
  • [26] What is controlled for in placebo-controlled trials?
    Fillingim, RB
    Price, DD
    MAYO CLINIC PROCEEDINGS, 2005, 80 (09) : 1119 - 1121
  • [27] Efficacy, Effectiveness, Pragmatic Trials - Guidance on Terminology and the Advantages of Pragmatic Trials
    Witt, Claudia M.
    FORSCHENDE KOMPLEMENTARMEDIZIN, 2009, 16 (05): : 292 - 294
  • [28] Monitoring in pragmatic trials lessons from the NIH pragmatic trials collaboratory
    Curtis, Lesley H.
    Morain, Stephanie
    O'Rourke, P. Pearl
    Staman, Karen
    Jarvik, Jeffrey G.
    Cheville, Andrea
    Dailey, Dana L.
    Sluka, Kathleen A.
    Heagerty, Patrick
    Melnick, Edward R.
    Chakraborty, Hrishikesh
    Tulsky, James A.
    Volandes, Angelo
    Simon, Gregory E.
    CONTEMPORARY CLINICAL TRIALS, 2025, 152
  • [29] What are randomised controlled trials good for?
    Nancy Cartwright
    Philosophical Studies, 2010, 147 : 59 - 70
  • [30] Understanding preferences regarding consent for pragmatic trials in acute care
    Dickert, Neal W.
    Wendler, David
    Devireddy, Chandan M.
    Goldkind, Sara F.
    Ko, Yi-An
    Speight, Candace D.
    Kim, Scott Y. H.
    CLINICAL TRIALS, 2018, 15 (06) : 567 - 578